PHARMACEUTICAL FORMULATION
A formulation for oral administration comprises an expectorant, an analgesic, and at least one additional active ingredient having a modified release providing a therapeutic effect for each of the active ingredients for up to 12 hours. Une formulation pour l'administration par voie orale compre...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | QIU, HONGCHUN BOROVICKA, JOSEF WOODHOUSE, ERNEST KASER, MATTHEW WILKINSON, ELLIOT CAVATUR, RAGHU CHEN, KEVIN |
| description | A formulation for oral administration comprises an expectorant, an analgesic, and at least one additional active ingredient having a modified release providing a therapeutic effect for each of the active ingredients for up to 12 hours.
Une formulation pour l'administration par voie orale comprend un expectorant, un analgésique, et au moins un autre ingrédient actif ayant une libération modifiée produisant un effet thérapeutique pour chacun des ingrédients actifs pendant 12 heures au maximum. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3001337A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3001337A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3001337A13</originalsourceid><addsrcrecordid>eNrjZJAK8HAM8nV0dg0N8XR29FFw8w_yDfVxDPH09-NhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfHOjsYGBobGxuaOhsZEKAEABBkf3A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL FORMULATION</title><source>esp@cenet</source><creator>QIU, HONGCHUN ; BOROVICKA, JOSEF ; WOODHOUSE, ERNEST ; KASER, MATTHEW ; WILKINSON, ELLIOT ; CAVATUR, RAGHU ; CHEN, KEVIN</creator><creatorcontrib>QIU, HONGCHUN ; BOROVICKA, JOSEF ; WOODHOUSE, ERNEST ; KASER, MATTHEW ; WILKINSON, ELLIOT ; CAVATUR, RAGHU ; CHEN, KEVIN</creatorcontrib><description>A formulation for oral administration comprises an expectorant, an analgesic, and at least one additional active ingredient having a modified release providing a therapeutic effect for each of the active ingredients for up to 12 hours.
Une formulation pour l'administration par voie orale comprend un expectorant, un analgésique, et au moins un autre ingrédient actif ayant une libération modifiée produisant un effet thérapeutique pour chacun des ingrédients actifs pendant 12 heures au maximum.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170413&DB=EPODOC&CC=CA&NR=3001337A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170413&DB=EPODOC&CC=CA&NR=3001337A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>QIU, HONGCHUN</creatorcontrib><creatorcontrib>BOROVICKA, JOSEF</creatorcontrib><creatorcontrib>WOODHOUSE, ERNEST</creatorcontrib><creatorcontrib>KASER, MATTHEW</creatorcontrib><creatorcontrib>WILKINSON, ELLIOT</creatorcontrib><creatorcontrib>CAVATUR, RAGHU</creatorcontrib><creatorcontrib>CHEN, KEVIN</creatorcontrib><title>PHARMACEUTICAL FORMULATION</title><description>A formulation for oral administration comprises an expectorant, an analgesic, and at least one additional active ingredient having a modified release providing a therapeutic effect for each of the active ingredients for up to 12 hours.
Une formulation pour l'administration par voie orale comprend un expectorant, un analgésique, et au moins un autre ingrédient actif ayant une libération modifiée produisant un effet thérapeutique pour chacun des ingrédients actifs pendant 12 heures au maximum.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAK8HAM8nV0dg0N8XR29FFw8w_yDfVxDPH09-NhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfHOjsYGBobGxuaOhsZEKAEABBkf3A</recordid><startdate>20170413</startdate><enddate>20170413</enddate><creator>QIU, HONGCHUN</creator><creator>BOROVICKA, JOSEF</creator><creator>WOODHOUSE, ERNEST</creator><creator>KASER, MATTHEW</creator><creator>WILKINSON, ELLIOT</creator><creator>CAVATUR, RAGHU</creator><creator>CHEN, KEVIN</creator><scope>EVB</scope></search><sort><creationdate>20170413</creationdate><title>PHARMACEUTICAL FORMULATION</title><author>QIU, HONGCHUN ; BOROVICKA, JOSEF ; WOODHOUSE, ERNEST ; KASER, MATTHEW ; WILKINSON, ELLIOT ; CAVATUR, RAGHU ; CHEN, KEVIN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3001337A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2017</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>QIU, HONGCHUN</creatorcontrib><creatorcontrib>BOROVICKA, JOSEF</creatorcontrib><creatorcontrib>WOODHOUSE, ERNEST</creatorcontrib><creatorcontrib>KASER, MATTHEW</creatorcontrib><creatorcontrib>WILKINSON, ELLIOT</creatorcontrib><creatorcontrib>CAVATUR, RAGHU</creatorcontrib><creatorcontrib>CHEN, KEVIN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>QIU, HONGCHUN</au><au>BOROVICKA, JOSEF</au><au>WOODHOUSE, ERNEST</au><au>KASER, MATTHEW</au><au>WILKINSON, ELLIOT</au><au>CAVATUR, RAGHU</au><au>CHEN, KEVIN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL FORMULATION</title><date>2017-04-13</date><risdate>2017</risdate><abstract>A formulation for oral administration comprises an expectorant, an analgesic, and at least one additional active ingredient having a modified release providing a therapeutic effect for each of the active ingredients for up to 12 hours.
Une formulation pour l'administration par voie orale comprend un expectorant, un analgésique, et au moins un autre ingrédient actif ayant une libération modifiée produisant un effet thérapeutique pour chacun des ingrédients actifs pendant 12 heures au maximum.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA3001337A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | PHARMACEUTICAL FORMULATION |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T05%3A39%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=QIU,%20HONGCHUN&rft.date=2017-04-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3001337A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |